Adler Reid G. bought VTGN
December 29, 2023 · Form 4 insider transaction
Adler Reid G. bought 167 shares of Vistagen Therapeutics, Inc. at $1.72 per share, a transaction worth $286.74. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
167
Price
$1.72
Total value
$286.74
InsiderAdler Reid G.
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 29, 2023
Filing dateJanuary 3, 2024
Shares owned after11,655
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares purchased pursuant to the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan.